Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1996-06-20
1998-06-09
Krass, Frederick
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 15, A61K 3816, A61K 3821
Patent
active
057633983
ABSTRACT:
A pharmaceutical composition for single, effective and consistent plasma level, nasal administration of an aqueous solution of from about 5 to about 75 .mu.l and from about 0.2 to about 2.0 mg/ml of desmopressin acetate, a molarly corresponding amount of desmopressin or a pharmaceutically acceptable salt: of desmopressin. The composition is useful for the management of urinary disorders such as diabetes insipidus, incontinence, and nocturnal enuresis.
REFERENCES:
patent: 3497491 (1970-02-01), Zaoral et al.
patent: 3794633 (1974-02-01), Kamber et al.
patent: 3929758 (1975-12-01), Hughes et al.
patent: 4033940 (1977-07-01), Hughes et al.
patent: 4093610 (1978-06-01), Abraham et al.
patent: 4216141 (1980-08-01), Rivier et al.
patent: 4271068 (1981-06-01), Kamber et al.
patent: 4351764 (1982-09-01), Birr
patent: 4487765 (1984-12-01), de Wied
patent: 5066716 (1991-11-01), Robey et al.
patent: 5482931 (1996-01-01), Harris et al.
patent: 5498598 (1996-03-01), Harris
patent: 5500413 (1996-03-01), Larsson et al.
Harris et al, "Effects of Concentration and Volume on Nasal Bioavailability and Biological Response to Desmopressin", Journal of Pharmaceutical Sciences, vol. 77, No. 4, Apr. 1988.
Ferring B.V.
Krass Frederick
LandOfFree
Nasal administration of desmopressin does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Nasal administration of desmopressin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nasal administration of desmopressin will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2199121